🟢 HCW Biologics is trading 5.56% up in after-hours trading

HCW Biologics is trading at $1.33, up 5.56% after hours, with no verified October 13 announcement or other clear catalyst identified.

• It closed the regular session at $1.26 on October 13, 2026.
• FDA guidance reported October 9 concerns IND preparation; filing remains targeted for the first half of 2027, making it earlier news, not a clear explanation.
• Nasdaq was down 2.20% during the session, which does not explain the after-hours gain; no reliable after-hours volume information was found.